VMP 39693511000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ibandronic acid 50mg tablets
BNF code 0606020W0AAABAB
Virtual Therapeutic Moiety Ibandronic acid
Date identifier became valid 26 May 2021
Previous product identifier 410948006
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 13 Sep 2004
Previous name Ibandronic acid 50 mg tablets
Basis of previous name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Ibandronic sodium monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 420936009
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Bondronat 50mg tablets (Atnahs Pharma UK Ltd)
Iasibon 50mg tablets (Aspire Pharma Ltd)
Ibandronic acid 50mg tablets (A A H Pharmaceuticals Ltd)
Ibandronic acid 50mg tablets (Accord-UK Ltd)
Ibandronic acid 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Ibandronic acid 50mg tablets (Aspire Pharma Ltd)
Ibandronic acid 50mg tablets (Consilient Health Ltd)
Ibandronic acid 50mg tablets (Medihealth (Northern) Ltd)
Ibandronic acid 50mg tablets (Phoenix Healthcare Distribution Ltd)
Ibandronic acid 50mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Ibandronic acid 50mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback